<DOC>
	<DOCNO>NCT01722695</DOCNO>
	<brief_summary>The purpose study show equivalent performance Revaclear dialyzer compare dialyzer large membrane surface area . Study design : open , randomize , cross-over , multicentric , control prospective Medical device : Revaclear 200 versus FX 60 Revaclear 400 versus FX 100 , depend patient need Patients/sample size : 30 adult chronic hemodialysis patient Treatment : Each patient treat hemodialysis one week ( 3 dialysis session ) Revaclear dialyzer one week ( 3 dialysis session ) FX dialyzer . Objectives : intraindividual comparison dialysis dose ; reduction rate total removal urea , phosphate , creatinine ß2-microglobulin ; albumin loss Primary variable : dialysis dose Kt/V urea Secondary variable : reduction rate total removal urea , phosphate , creatinine ß2-microglobulin Safety variable : albumin loss , blood count</brief_summary>
	<brief_title>Performance Comparison Revaclear With Larger Dialyzer</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>chronic renal failure stable treatment hemodialysis hemodiafiltration least 3 month patient age 18 year write consent participate study ( informed consent ) dialysis via native fistula GoreTex graft capable provide blood flow rate least 300 mL/min singleneedle dialysis pregnant lactate woman participation interventional study less 3 month prior study start noncompliance dialysis prescription hematocrit le 28 % hospitalization antibiotic therapy active infection active cancer know positive serology HIV , hepatitis B C serious hemostasis disorder comorbidity possibly conflict study purpose procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>